ABN AMRO Bank N. V. Buys New Stake in Cardinal Health, Inc. $CAH
ABN AMRO Bank N. V. purchased a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund purchased 14,130 shares of the company's stock, valued at approximately $3,342,000. Several other hedge funds have also bo
ABN AMRO Bank N. V. purchased a new stake in Cardinal Health, Inc. (NYSE:CAH-Free Report) during the second quarter, according to its most recent filing with the SEC. The fund purchased 14,130 shares of the company's stock, valued at approximately $3,342,000. GetCardinal Healthalerts:Cardinal Health Earnings: Can Perfection Get Priced In Twice?Several other hedge funds have also bought and sold shares of CAH. LWM Advisors Inc. boosted its stake in Cardinal Health by 4. 4% during the second quarter. LWM Advisors Inc. now owns 1,028 shares of the company's stock valued at $244,000 after buying an additional 43 shares during the last quarter. Kathmere Capital Management LLC raised its holdings in shares of Cardinal Health by 1. 2% during the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company's stock worth $896,000 after acquiring an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. raised its holdings in shares of Cardinal Health by 0. 9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company's stock worth $1,184,000 after acquiring an additional 50 shares in the last quarter. V Square Quantitative Management LLC boosted its position in shares of Cardinal Health by 2. 6% during the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company's stock valued at $423,000 after acquiring an additional 50 shares during the last quarter. Finally, Generali Asset Management SPA SGR boosted its position in shares of Cardinal Health by 11. 0% during the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company's stock valued at $105,000 after acquiring an additional 51 shares during the last quarter. Hedge funds and other institutional investors own 87. 17% of the company's stock. Analysts Set New Price TargetsCAH has been the topic of several research reports. Citigroup boosted their price target on shares of Cardinal Health from $265. 00 to $280. 00 and gave the stock a "buy" rating in a research report on Wednesday. Mizuho upped their target price on shares of Cardinal Health from $240. 00 to $250. 00 and gave the company an "outperform" rating in a research report on Wednesday. Leerink Partners set a $292. 00 price target on shares of Cardinal Health in a report on Tuesday. Evercore reiterated an "outperform" rating and issued a $270. 00 price target on shares of Cardinal Health in a research report on Wednesday. Finally,Wall Street Zenraised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat. com, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average price target of $265. 93. McKesson's Compounding Keeps Adding UpRead Our Latest Stock Report on Cardinal HealthCardinal Health Price PerformanceShares ofNYSE CAHopened at $234. 92 on Friday. Cardinal Health, Inc. has a 1 year low of $145. 87 and a 1 year high of $258. 30. The firm has a 50-day simple moving average of $230. 30 and a two-hundred day simple moving average of $217. 14. The company has a market cap of $54. 64 billion, a P/E ratio of 32. 49, a PEG ratio of 1. 39 and a beta of 0. 49. Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and DoubtCardinal Health (NYSE:CAH-Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported $2. 91 earnings per share for the quarter, topping the consensus estimate of $2. 42 by $0. 49. Cardinal Health had a negative return on equity of 98. 53% and a net margin of 0. 67%. The firm had revenue of $63. 67 billion for the quarter, compared to the consensus estimate of $65. 15 billion. During the same period in the prior year, the business posted $2. 08 earnings per share. The company's revenue for the quarter was up 5. 8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12. 400-12. 600 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 12. 55 EPS for the current year. Cardinal Health Announces DividendThe company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0. 5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2. 06 dividend on an annualized basis and a dividend yield of 0. 9%. Cardinal Health's payout ratio is presently 28. 49%. Cardinal Health Company Profile(Free Report)Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories. The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions. See AlsoFive stocks we like better than Cardinal HealthIs Best Buy the AI Winner Hiding in the Electronics Aisle?Applied Materials Beat Everything but Wall Street’s Expectations for MarginsBack From Orbit, Intuitive Machines' Share Price Enters the Buy ZoneTexas Roadhouse and Brinker International Have the Recipe Rivals Are MissingThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Cardinal Health Right Now?Before you consider Cardinal Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Cardinal Health wasn't on the list. While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereThe space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important. Get This Free Report